# Inherited deficiency of DIAPH1 identifies a DNA double strand break repair pathway regulated by γ-actin

**Authors:** Beth L. Woodward, Sudipta Lahiri, Anoop S. Chauhan, Marcos Rios Garcia, Lucy E. Goodley, Thomas L. Clarke, Mohinder Pal, Angelo Agathanggelou, Satpal S. Jhujh, Anil N. Ganesh, Fay M. Hollins, Valentina Galassi Deforie, Reza Maroofian, Stephanie Efthymiou, Andrea Meinhardt, Christopher G. Mathew, Michael A. Simpson, Heather C. Mefford, Eissa A. Faqeih, Sergio D. Rosenzweig, Stefano Volpi, Gigliola Di Matteo, Caterina Cancrini, Annarita Scardamaglia, Fiona Shackley, E. Graham Davies, Shahnaz Ibrahim, Peter D. Arkwright, Maha S. Zaki, Tatjana Stankovic, A. Malcolm R. Taylor, Antonina J. Mazur, Nataliya Di Donato, Henry Houlden, Eli Rothenberg, Grant S. Stewart

PMC · DOI: 10.1038/s41467-025-59553-0 · Nature Communications · 2025-05-14

## TL;DR

This study shows that DIAPH1 and γ-actin help repair DNA breaks through homologous recombination, and their mutations cause clinical symptoms similar to HR deficiency disorders.

## Contribution

Identifies DIAPH1 and γ-actin as regulators of HR-dependent DNA repair and links their mutations to HR deficiency-like clinical features.

## Key findings

- Cells from DIAL syndrome patients show HR repair defects similar to NBS1 loss.
- BWCFF syndrome patients with ACTG1 mutations also exhibit DSBR defects.
- DIAPH1 and γ-actin facilitate MRE11/RAD50/NBS1 complex relocalization to DNA breaks.

## Abstract

DNA double strand break repair (DSBR) represents a fundamental process required to maintain genome stability and prevent the onset of disease. Whilst cell cycle phase and the chromatin context largely dictate which repair pathway is utilised to restore damaged DNA, it has been recently shown that nuclear actin filaments play a major role in clustering DNA breaks to facilitate DSBR by homologous recombination (HR). However, the mechanism with which nuclear actin and the different actin nucleating factors regulate HR is unclear. Interestingly, patients with biallelic mutations in the actin nucleating factor DIAPH1 exhibit a striking overlap of clinical features with the HR deficiency disorders, Nijmegen Breakage Syndrome (NBS) and Warsaw Breakage Syndrome (WABS). This suggests that DIAPH1 may play a role in regulating HR and that some of the clinical deficits associated with DIAPH1 mutations may be caused by an underlying DSBR defect. In keeping with this clinical similarity, we demonstrate that cells from DIAL (DIAPH1 Loss-of-function) Syndrome patients display an HR repair defect comparable to loss of NBS1. Moreover, we show that this DSBR defect is also observed in a subset of patients with Baraitser-Winter Cerebrofrontofacial (BWCFF) syndrome associated with mutations in ACTG1 (γ-actin) but not ACTB (β-actin). Lastly, we demonstrate that DIAPH1 and γ-actin promote HR-dependent repair by facilitating the relocalisation of the MRE11/RAD50/NBS1 complex to sites of DNA breaks to initiate end-resection. Taken together, these data provide a mechanistic explanation for the overlapping clinical symptoms exhibited by patients with DIAL syndrome, BWCFF syndrome and NBS.

DNA double strand break repair pathways ensure genome stability and prevent disease. Here the authors show that the actin nucleating factor DIAPH1 and γ-actin promote homologous recombination (HR)-dependent repair. Inherited mutations in DIAPH1 or ACTG1 give rise to clinical deficits similar to those associated with defective HR.

## Linked entities

- **Genes:** DIAPH1 (diaphanous related formin 1) [NCBI Gene 1729], ACTG1 (actin gamma 1) [NCBI Gene 71], ACTB (actin beta) [NCBI Gene 60], NBN (nibrin) [NCBI Gene 4683], MRE11 (MRE11 double strand break repair nuclease) [NCBI Gene 4361], RAD50 (RAD50 double strand break repair protein) [NCBI Gene 10111], NBN (nibrin) [NCBI Gene 4683]
- **Proteins:** Act5C (Actin 5C), actb (actin beta)
- **Diseases:** Nijmegen Breakage Syndrome (MONDO:0009623), Warsaw Breakage Syndrome (MONDO:0013252), Baraitser-Winter Cerebrofrontofacial syndrome (MONDO:0017579)

## Full-text entities

- **Genes:** WASL (WASP like actin nucleation promoting factor) [NCBI Gene 8976] {aka N-WASP, NWASP, WASPB}, CHEK2 (checkpoint kinase 2) [NCBI Gene 11200] {aka CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53}, ARPC1B (actin related protein 2/3 complex subunit 1B) [NCBI Gene 10095] {aka ARC41, IMD71, PLTEID, p40-ARC, p41-ARC}, RBBP8 (RB binding protein 8, endonuclease) [NCBI Gene 5932] {aka COM1, CTIP, JAWAD, JWDS, RIM, SAE2}, NBN (nibrin) [NCBI Gene 4683] {aka AT-V1, AT-V2, ATV, NBS, NBS1, P95}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, SMC1A (structural maintenance of chromosomes 1A) [NCBI Gene 8243] {aka CDLS2, DEE85, DXS423E, EIEE85, SB1.8, SMC1}, FLNB (filamin B) [NCBI Gene 2317] {aka ABP-278, ABP-280, FH1, FLN-B, FLN1L, LRS1}, MDC1 (mediator of DNA damage checkpoint 1) [NCBI Gene 9656] {aka NFBD1}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, Mre11a (MRE11A homolog A, double strand break repair nuclease) [NCBI Gene 17535] {aka Mre11, Mre11b}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, WAS (WASP actin nucleation promoting factor) [NCBI Gene 7454] {aka IMD2, SCNX, THC, THC1, WASP, WASPA}, RAD50 (RAD50 double strand break repair protein) [NCBI Gene 10111] {aka NBSLD, RAD502, hRad50}, SNRNP70 (small nuclear ribonucleoprotein U1 subunit 70) [NCBI Gene 6625] {aka RNPU1Z, RPU1, SNRP70, Snp1, U1-70K, U170K}, TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, MRE11 (MRE11 double strand break repair nuclease) [NCBI Gene 4361] {aka ATLD, HNGS1, MRE11A, MRE11B}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, CAT (catalase) [NCBI Gene 847], Tfpi (tissue factor pathway inhibitor) [NCBI Gene 21788] {aka A630013F22Rik, EPI, LACI}, DIAPH3 (diaphanous related formin 3) [NCBI Gene 81624] {aka AN, AUNA1, DIA2, DRF3, NSDAN, diap3}, DIAPH1 (diaphanous related formin 1) [NCBI Gene 1729] {aka DFNA1, DIA1, DRF1, LFHL1, SCBMS, hDIA1}, ICR1 [NCBI Gene 3388], RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, ACTG1 (actin gamma 1) [NCBI Gene 71] {aka ACT, ACTG, DFNA20, DFNA26, HEL-176}, ACTR2 (actin related protein 2) [NCBI Gene 10097] {aka ARP2}, Diaph1 (diaphanous related formin 1) [NCBI Gene 13367] {aka D18Wsu154e, Dia1, Diap1, Drf1, p140mDia}, WASH6P (WASP family homolog 6, pseudogene) [NCBI Gene 653440] {aka CXYorf1, FAM39A, WASH}, TRIM28 (tripartite motif containing 28) [NCBI Gene 10155] {aka KAP1, PPP1R157, RNF96, TF1B, TIF1B, TIF1beta}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, RPA2 (replication protein A2) [NCBI Gene 6118] {aka REPA2, RP-A p32, RP-A p34, RPA32}, ARPC5 (actin related protein 2/3 complex subunit 5) [NCBI Gene 10092] {aka ARC16, IMD113, dJ127C7.3, p16-Arc}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, Trap [NCBI Gene 100187907], BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, CENPF (centromere protein F) [NCBI Gene 1063] {aka CENF, CILD31, PRO1779, STROMS, hcp-1}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, ARPC4 (actin related protein 2/3 complex subunit 4) [NCBI Gene 10093] {aka ARC20, DEVLO, P20-ARC}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** BCWFF syndrome (MESH:D013577), hypothyroidism (MESH:D007037), MDS (MESH:D009190), thrombocytopenia (MESH:D013921), DSBR deficiency (MESH:D019457), Hodgkin lymphoma (MESH:D006689), WABS (OMIM:613398), hypersensitivity (MESH:D004342), Fanconi Anaemia (MESH:D000743), BWCFF (OMIM:243310), coloboma (MESH:D003103), DIAPH1 deficiency (MESH:D007153), neurodevelopmental defects (MESH:D065886), actin dysfunction (MESH:C564942), neurodevelopmental disease (MESH:D004194), midline facial granuloma (MESH:D006103), respiratory infections (MESH:D012141), impaired vision (MESH:D014786), intellectual disabilities (MESH:D008607), haematological abnormalities (MESH:D006402), genetic disorders (MESH:D030342), kidney defects (MESH:D007674), B cell lymphoma (MESH:D016393), facial dysmorphia (MESH:C537340), melanoma (MESH:D008545), DNA repair disorders (MESH:D049914), lymphopenia (MESH:D008231), DNA (MESH:D004266), NBS (MESH:D049932), haematological malignancies (MESH:D009369), infections (MESH:D007239), AML (MESH:D015470), blindness (MESH:D001766), SCBMS (OMIM:616632), mycoplasma (MESH:D009175), Seizures (MESH:D012640), autosomal recessive neurodevelopmental disorder (MESH:D002658), IR (MESH:D011832), Cortical Blindness (MESH:D019575), A-T (MESH:D001260), hearing impairment (MESH:D034381), non-syndromic hearing loss (MESH:C537845), neurodevelopmental deficits (MESH:D009461), cardiac abnormalities (MESH:D018376), developmental abnormalities (MESH:D006130), HR (MESH:C535296), WAS (MESH:D014923), Microcephaly (MESH:D008831), neurodevelopmental abnormalities (MESH:D063647), lymphoid tumours (MESH:D018442), behavioural abnormalities (MESH:D000014), DIAL (MESH:D006315)
- **Chemicals:** ethanol (MESH:D000431), MgCl2 (MESH:D015636), NH4Cl (MESH:D000643), Triton X-100 (MESH:D017830), Lipofectamine 2000 (MESH:C086724), glucose (MESH:D005947), methanol (MESH:D000432), AF647 (MESH:C569686), glycine (MESH:D005998), CPT (MESH:D002166), oil (MESH:D009821), Giemsa (MESH:D001399), PBS (MESH:D007854), BrdU (MESH:D001973), DAPI (MESH:C007293), Hoechst 33342 (MESH:C017807), ETOP (MESH:D005047), Sucrose (MESH:D013395), Oligofectamine (MESH:C484027), NP40 (MESH:C010615), Olaparib (MESH:C531550), PIPES (MESH:C008916), HCl (MESH:D006851), methylene blue (MESH:D008751), mercaptoethylamine (MESH:D003543), streptomycin (MESH:D013307), 4-hydroxytamoxifen (MESH:C016601), HEPES (MESH:D006531), ATMi (-), 4-OHT (MESH:C032278), Colcemid (MESH:D003703), KU-55933 (MESH:C495818), l-glutamine (MESH:D005973), NaCl (MESH:D012965), Sodium Azide (MESH:D019810), SDS (MESH:D012967), Urea (MESH:D014508), Alexa Fluor 488 (MESH:C000711379), penicillin (MESH:D010406), agarose (MESH:D012685), Hygromycin (MESH:C026273), water (MESH:D014867), EdU (MESH:C022811), mirin (MESH:C526365), aphidicolin (MESH:D016590), PFA (MESH:C003043), EDTA (MESH:D004492), acetic acid (MESH:D019342), PLA (MESH:C033616), KCl (MESH:D011189)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Drosophila melanogaster (fruit fly, species) [taxon 7227], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** I862A, p.Arg183Trp, E0554S, c.2108dupC, c.657del5, D10A, p.Pro704Thrfs
- **Cell lines:** fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), AsiSI-ER — Homo sapiens (Human), Limb-girdle muscular dystrophy type 2B, Telomerase immortalized cell line (CVCL_VG62), H6278-10MG — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_LK65), pLV-hTERT — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_EE25), 293FT — Homo sapiens (Human), Transformed cell line (CVCL_6911), U-2 OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), A375 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0132), pMD2.G — Homo sapiens (Human), Hybridoma (CVCL_A6KF), DIAPH1-P5 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_SK83)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12078678/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12078678/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12078678/full.md

---
Source: https://tomesphere.com/paper/PMC12078678